PTC Therapeutics Inc (NASDAQ:PTCT)

64.85
Delayed Data
As of Mar 30
 +2.23 / +3.56%
Today’s Change
14.51
Today|||52-Week Range
77.87
+25.27%
Year-to-Date

Today’s Trading

Previous close62.62
Today’s open63.25
Day’s range61.20 - 64.98
Volume604,698
Average volume (3 months)570,754
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-69.98%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book6.90

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp+0.09+1.72%
IRWDIronwood Pharmaceuti...+0.86+5.49%
RAREUltragenyx Pharmaceu...+4.39+7.76%
INSYINSYS Therapeutics I...+0.79+1.40%
Data as of 4:00pm ET, 03/30/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Financial Officer
Shane William Charles Kovacs
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account